Genomtec S.A. Cash Flow-to-Debt Ratio
Genomtec S.A. cash flow-to-debt ratio. Genomtec S.A. (GMT) has a Cash Flow-to-Debt Ratio of -0.31x as of March 2026, meaning its operating cash flow of zł-1.84 Million could theoretically repay 0% of its total liabilities (zł6.01 Million) in one year. See how financially flexible is Genomtec S.A. to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Genomtec S.A. (2019–2024)
Cash flow-to-debt ratio of Genomtec S.A. from 2019 to 2024. Historical debt coverage capacity for Genomtec S.A. across 6 annual periods. Check GMT total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Genomtec S.A. Cash Flow-to-Debt Ratio by Year (2019–2024)
Genomtec S.A. cash flow-to-debt ratio by year from 2019 to 2024. Year-by-year debt coverage analysis for Genomtec S.A.. For the full cash flow conversion analysis, see GMT operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (PLN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.71x | zł-6.72 Million | zł9.44 Million | ▲ +31.4% |
| 2023 | -1.04x | zł-7.95 Million | zł7.67 Million | ▼ -88.0% |
| 2022 | -0.55x | zł-3.79 Million | zł6.87 Million | ▲ +65.3% |
| 2021 | -1.59x | zł-5.53 Million | zł3.48 Million | ▼ -13.7% |
| 2020 | -1.40x | zł-2.52 Million | zł1.80 Million | ▼ -48.6% |
| 2019 | -0.94x | zł-1.69 Million | zł1.80 Million | — |